❤️ China-PAR 10-Year ASCVD Risk
UsePrimary-prevention cardiovascular risk assessment in Chinese adults without established ASCVD.
Loading calculator…
SourceYang X, et al. Circulation 2016
Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
- Who it is for
- Adults using the Chinese population model for 10-year risk and a lipid-intensity band.
- Who it is not for
- US PCE is not the main door for ASCVD in China. Pregnancy does not enter statin intensity; contraindication or caution only.
- Formula and variables
- The main door is China-PAR, the equation already on this page: sex, age, region, urban or rural, waist, treated or untreated systolic pressure, total cholesterol, HDL cholesterol, smoking, diabetes, family history, and the rest. Coefficients stay as on this page and are not changed. This equation is not the risk-factor counting flowchart. Until that crosswalk is pinned, the two cannot be swapped automatically.
- Result → next step
- Give the risk band first. The main door for ASCVD in China is China-PAR, not US PCE. An LDL-cholesterol target band may open the existing target page, but a China-PAR percent must not be dropped straight into a flowchart cell. Intensity band or defer only. No numeric dose. Pregnancy uses the pregnancy-medication page for contraindication or caution only.LDL-C target band →Pregnancy meds (contraindication or caution) →
- Guideline
- China blood lipid guideline 2023
Scene next step
📋ASCVD / China-PAROpen scene pack →Related scores
Matching pathway
🧭htn_emergencyOpen pathway →Score + version; reference only — not a substitute for care · no HIS write
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Clinical takeaway
Common strata: <5% low, 5–<10% moderate, ≥10% high.
When to use
Primary-prevention cardiovascular risk assessment in Chinese adults without established ASCVD.
How it works
Sex-specific log model (Yang 2016; T/JPMA 024—2024): age, SBP (±treatment), TC, HDL, waist, smoking, diabetes, north/south, urban (men), family history (men); cholesterol mmol/L ×38.6 to mg/dL.
Key points
- Common strata: <5% low, 5–<10% moderate, ≥10% high.
- Validated example ~10.8% men / ~10.2% women.
- Not for established ASCVD.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Age (20–85) | 55 years |
|---|---|
| Sex | Male |
| Systolic BP | 130 mmHg |
| On antihypertensive treatment | No |
| Total cholesterol | 5.0 mmol/L |
| HDL cholesterol | 1.2 mmol/L |
| Waist circumference | 85 cm |
| Current smoker | No |
| Diabetes | No |
| Northern residence (north of Qinling–Huaihe) | No (South) |
| Urban residence (counted for men) | Rural |
| Family history of CVD (counted for men) | No |
→10-year ASCVD risk4.1% · low (<5%)
- Strata：<5% low, 5–<10% moderate, ≥10% high (common Chinese practice cut-offs).
- Model：China-PAR (Yang 2016; T/JPMA 024—2024 coeffs; cholesterol mmol/L → ×38.6 mg/dL).
| Age (20–85) | 55 years |
|---|---|
| Sex | Female |
| Systolic BP | 130 mmHg |
| On antihypertensive treatment | Yes |
| Total cholesterol | 5.0 mmol/L |
| HDL cholesterol | 1.2 mmol/L |
| Waist circumference | 85 cm |
| Current smoker | Yes |
| Diabetes | Yes |
| Northern residence (north of Qinling–Huaihe) | Yes (North) |
| Urban residence (counted for men) | Urban |
| Family history of CVD (counted for men) | Yes |
→10-year ASCVD risk17.2% · high (≥10%)
- Strata：<5% low, 5–<10% moderate, ≥10% high (common Chinese practice cut-offs).
- Model：China-PAR (Yang 2016; T/JPMA 024—2024 coeffs; cholesterol mmol/L → ×38.6 mg/dL).
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using China-PAR 10-Year ASCVD Risk?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does China-PAR 10-Year ASCVD Risk upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is China-PAR 10-Year ASCVD Risk calculated in practice? Can you show a worked example?
- Inputs: Age (20–85) 55 years, Sex Male, Systolic BP 130 mmHg, On antihypertensive treatment No, Total cholesterol 5.0 mmol/L, HDL cholesterol 1.2 mmol/L, Waist circumference 85 cm, Current smoker No… → Result: 10-year ASCVD risk 4.1 % · low (<5%)（Strata: <5% low, 5–<10% moderate, ≥10% high (common Chinese practice cut-offs)., Model: China-PAR (Yang 2016; T/JPMA 024—2024 coeffs; cholesterol mmol/L → ×38.6 mg/dL).） Inputs: Age (20–85) 55 years, Sex Female, Systolic BP 130 mmHg, On antihypertensive treatment Yes, Total cholesterol 5.0 mmol/L, HDL cholesterol 1.2 mmol/L, Waist circumference 85 cm, Current smoker Yes… → Result: 10-year ASCVD risk 17.2 % · high (≥10%)（Strata: <5% low, 5–<10% moderate, ≥10% high (common Chinese practice cut-offs)., Model: China-PAR (Yang 2016; T/JPMA 024—2024 coeffs; cholesterol mmol/L → ×38.6 mg/dL).）